Turkey | Egypt | Ukraine | Kazakhstan | Poland | Global | |
Population in 2020 | 84,339,067 | 102,334,404 | 43,733,762 | 18,776,707 | 37,846,611 | 7,845,261,000 |
% above 65 years | 8.7% | 5.3% | 16.7% | 7.7% | 18.1% | 9.09% |
Cases | 8,432,018 | 344,907 | 3,244,749 | 1,039,671 | 3,230,634 | 253,640,693 |
(per 1,000 population) | (99.98) | (3.37) | (74.19) | (55.37) | (85.36) | (32.33) |
Deaths | 73,746 | 19,567 | 77,985 | 17,549 | 79,161 | 5,104,899 |
(per 1,000 population) | (0.87) | (0.19) | (1.78) | (0.93) | (2.09) | (0.65) |
Vaccine dose total | 117,378,532 | 33,667,594 | 19,322,408 | 16,046,796 | 39,587,985 | 7,307,892,664 |
(per 100 population) | (139.17) | (32.9) | (44.18) | (85.46) | (104.6) | (93.15) |
Vaccine dose-1 (million) | 55.87 | 21.12 | 12.33 | 8.54 | 20.48 | 4,110 |
(%) | (66%) | (20%) | (28%) | (45%) | (54%) | (52%) |
Vaccine dose-2 (million) | 49.71 | 13.27 | 8.91 | 7.82 | 20.15 | 3,220 |
(%) | (58%) | (13%) | (20%) | (41%) | (53%) | (41%) |
Vaccine type | Pfizer | Sinopharm, AstraZeneca | AstraZeneca, Pfizer, Sinopharm | Sputnik V | Pfizer, Moderna | |
Vaccine roll out started | Apr 2, 2021 | Jan, 2021 | Feb 24, 2021 | Feb 1, 2021 | Dec 2, 2020 | |
Turkey | Egypt | Ukraine | Kazakhstan | Poland | EU average | |
Life expectancy at birth in 2018 (years) | 77 | 72 | 72 | 73 | 78 | 81 |
GDP per capita in 2019 (current US$) | 9,127 | 3,019 | 3,659 | 9,812 | 15,693 | 34,913 |
Health expenditure in 2019 (% of GDP) | 4.12 | 4.95 | 7.72 | 2.92 | 6.33 | 9.85 |
Hospital bed per 1,000 population in 2018 | 2.9 | 1.4 | 7.5 | 6.1 | 6.5 | 4.6 |
Physicians per 1,000 population in 2018 | 1.8 | 0.5 | 3.0 | 4.0 | 2.4 | 3.7 |